Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07282119 · ClinicalTrials.gov registry record · NA
Can EmeraldLED Reshape Your Body With Continued Use?
A NA study of Body Composition, sponsored by Efforia.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07282119: Recruiting NA study of Body Composition, sponsored by Efforia.
NCT07282119 is a NA study of Body Composition that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, below the 111-participant average among 20 other Body Composition trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07282119, a NA study of Body Composition, is actively recruiting participants, sponsored by Efforia.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive changes in body composition.
Primary Outcome
The Body Composition Measurement Form is specifically crafted to accurately track changes in body measurements relevant to individuals engaged in weight loss or bodybuilding. This form allows for the consistent recording of key physical metrics across various body parts, facilitating the evaluation of fitness progress. By using this form, individuals can obtain a clear picture of the physical changes resulting from their exercise routines and nutritional choices. Each measurement is to be record
Conditions Studied
Interventions
- DEVICE EmeraldLED
Study Locations (1)
New York
- Efforia - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-08-29 |
| Est. Completion | 2026-08-29 |
| Phase | NA |
What NCT07282119 shows while recruiting
NCT07282119 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 111-participant average among 20 other Body Composition trials with a reported enrollment target (10% lower).
The record links to 1 condition, with Body Composition appearing as the primary indexed condition, and to 1 intervention - of which EmeraldLED is the first listed.
NCT07282119 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07282119 about?
NCT07282119 is a clinical study titled "Can EmeraldLED Reshape Your Body With Continued Use?". Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive changes in body composition.
What is the current status of trial NCT07282119?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-08-29. Estimated completion is 2026-08-29.
What conditions does trial NCT07282119 study?
This clinical trial studies the following conditions: Body Composition.
What interventions are being tested in trial NCT07282119?
The interventions under investigation include: EmeraldLED (DEVICE).
Who is sponsoring clinical trial NCT07282119?
This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07282119 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Body Composition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07282119's enrollment target sits among peer trials
100 5th of 20 higher than 13 of 20 other Body Composition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Body Composition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
How Does Continued Use of Green Light Therapy Impact Outcomes?
RECRUITING · NA
-
ENRICH Nurse-Family Partnership Study
RECRUITING · NA
-
Feasibility and Potential Efficacy of Herbs and Spices for Improving Dietary Quality in College Students: A Pilot Study
RECRUITING · NA
-
Role of Body Composition in Large for Gestational Age Infants (LGA) With Oral Feeding Difficulty
RECRUITING · NA
-
Discover Better Body Composition With Green Light!
RECRUITING · NA
-
Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI